Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 3Phase EARLY_PHASE1 1

Status

Completed 10Recruiting 6Terminated 3Not yet recruiting 3Withdrawn 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Plasma cell 3Thoracic 1Other solid neoplasm 1Other hematologic neoplasm 1Lymphoid 1Gastrointestinal 1

Conditions

Breast Neoplasms 217Neoplasms 175Lung Neoplasms 94Prostatic Neoplasms 89Colorectal Neoplasms 89Carcinoma, Non-Small-Cell Lung 48Stomach Neoplasms 45Motor Activity 45Carcinoma, Hepatocellular 45Pancreatic Neoplasms 40Uterine Cervical Neoplasms 39Anxiety Disorders 39Rectal Neoplasms 34Head and Neck Neoplasms 31Colonic Neoplasms 30Pain 26Depression 26Esophageal Neoplasms 24Brain Neoplasms 24Disease 23Polycystic Ovary Syndrome 22Multiple Myeloma 22Hematologic Neoplasms 22Endometrial Neoplasms 22Ovarian Neoplasms 21Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Urinary Bladder Neoplasms 18Pain, Postoperative 18Leukemia, Myeloid, Acute 17Glioblastoma 17

Interventions

4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Not yet recruiting × Immunoglobulin Light-chain Amyloidosis × Clear all
NCT07624760 2026-06-03

MGUS-PET

University of Zurich

Phase NA Not yet recruiting
50 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Paraproteinemias

NCT06971848 2026-03-30

ETCABIO

University Hospital, Angers

Phase NA Not yet recruiting
70 enrolled
GastrointestinalLymphoidOther hematologic neoplasmOther solid neoplasmPlasma cellThoracic

Immunoglobulin Light-chain Amyloidosis, Esophageal Squamous Cell Carcinoma, Mesothelioma, Malignant, Carcinoma, Bronchogenic, Heart Neoplasms, Carcinoma, Hepatocellular, Lymphoma, Follicular, Colorectal Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Cholangiocarcinoma, Neoplasms, Plasma Cell

NCT07215494 2025-10-10

A Clinical Study on Minimal Residual Disease in Patients With Systemic Light Chain Amyloidosis

Peking University First Hospital

Phase NA Not yet recruiting
50 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡